Letter: trial of antitubercular therapy for diagnosing Crohn's disease in LMICs-double whammy?

Aliment Pharmacol Ther. 2023 Apr;57(7):815-816. doi: 10.1111/apt.17410.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Crohn Disease* / diagnosis
  • Crohn Disease* / drug therapy
  • Developing Countries
  • Double-Blind Method
  • Humans